Pembrolizumab,Gemcitabine,Cisplatin
Merck
[]
hope for rare cancers: novel targeted and immunological agents timothy a. yap, md, phd; peter szlosarek, md, phd; robin kate kelley, md; and kari kendra, md, phd, presented sunday at #aacr23. recap in aacr annual meeting news: 
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.